Article
Therapeutic targeting of IL-7Rα signaling pathways in ALL treatment
7 Jun 2016
Abstract excerpt
Increased understanding of pediatric acute lymphoblastic leukemia (ALL) pathobiology has led to dramatic improvements in patient survival. However, there is still a need to develop targeted therapies to enable reduced chemotherapy intensity and to treat relapsed patients. The interleukin-7 receptor α (IL-7Rα) signaling pathways are prime therapeutic targets because these pathways harbor genetic aberrations in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
